Subcutaneous panniculitis-like T-cell lymphoma post-mRNA-1273 COVID-19 vaccination

Sho Ukishima; Taiju Miyagami; Mari Arikawa; Seiko Kushiro; Tomoiku Takaku; Toshio Naito

doi:10.1002/ccr3.7143

Subcutaneous panniculitis-like T-cell lymphoma post-mRNA-1273 COVID-19 vaccination

Clin Case Rep. 2023 Apr 5;11(4):e7143. doi: 10.1002/ccr3.7143. eCollection 2023 Apr.

Authors

Sho Ukishima¹, Taiju Miyagami¹, Mari Arikawa¹, Seiko Kushiro¹, Tomoiku Takaku², Toshio Naito¹

Affiliations

¹ Department of General Medicine Juntendo University Faculty of Medicine Bunkyo-Ku Tokyo Japan.
² Department of Hematology Juntendo University School of Medicine Bunkyo-Ku Tokyo Japan.

Abstract

This is a case of subcutaneous panniculitis-like T-cell lymphoma (SPTCL) was diagnosed by skin biopsy in a patient who presented with fever and erythema nodosum in the umbilicum following mRNA-1273 COVID-19 vaccination. COVID-19 vaccines may cause SPTCL and skin biopsy may help in the diagnosis of erythema nodosum.

Keywords: COVID‐19 vaccination; T‐cell lymphoma; subcutaneous panniculitis‐like T‐cell lymphoma.

Publication types

Case Reports